Literature DB >> 8590808

Generation of truncated forms of the NG2 proteoglycan by cell surface proteolysis.

A Nishiyama1, X H Lin, W B Stallcup.   

Abstract

NG2 is a chondroitin sulfate proteoglycan that is expressed on dividing progenitor cells of several lineages including glia, muscle, and cartilage. It is an integral membrane proteoglycan with a core glycoprotein of 300 kDa. In the present study we have characterized three molecular forms of the NG2 core protein expressed by different cell lines. Many cell lines that express the full length 300-kDa NG2 core protein also release a 290-kDa form into the medium. This species lacks the cytoplasmic domain but contains almost the entire ectodomain. Two core protein species, the intact 300-kDa form and a truncated 275-kDa form, are expressed at the surface of an NG2-transfected cell line U251NG52. The 275-kDa species lacks the cytoplasmic domain and at least 64 amino acids of the ectodomain. Mild trypsinization of B49 cells also generates the 275-kDa species, suggesting that this component is produced by proteolysis of the 300-kDa form. Conversion of the 300-kDa species to the 275-kDa form in U251NG52 cells is stimulated by reagents such as phorbol esters, which activate protein kinase C. Phorbol esters are also known to induce expression of metalloproteinases such as collagenase and stromelysin, which could be responsible for cleavage of the 300-kDa core protein. Although B49 cells do not spontaneously produce the truncated 275-kDa species, use of monoclonal antibodies against NG2 to block the interaction between NG2 and type VI collagen results in the appearance of the 275-kDa component in these cells. Thus the interaction between NG2 and type VI collagen, which contains a Kunitz-type proteinase inhibitor sequence in the alpha 3 chain, may protect the proteoglycan against proteolysis. This is consistent with the observed deficiency of U251NG52 cells in anchoring type VI collagen at the surface.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8590808      PMCID: PMC301335          DOI: 10.1091/mbc.6.12.1819

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  45 in total

1.  Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase.

Authors:  T Tamaoki; H Nomoto; I Takahashi; Y Kato; M Morimoto; F Tomita
Journal:  Biochem Biophys Res Commun       Date:  1986-03-13       Impact factor: 3.575

Review 2.  The role of protein kinase C in cell surface signal transduction and tumour promotion.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1984 Apr 19-25       Impact factor: 49.962

3.  Antisera specific for cell lines with mixed neuronal and glial properties.

Authors:  S S Wilson; E E Baetge; W B Stallcup
Journal:  Dev Biol       Date:  1981-04-15       Impact factor: 3.582

4.  Cell-surface molecules that characterize different stages in the development of cerebellar interneurons.

Authors:  W B Stallcup; L Beasley; J Levine
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1983

5.  Clonal cell lines from the rat central nervous system.

Authors:  D Schubert; S Heinemann; W Carlisle; H Tarikas; B Kimes; J Patrick; J H Steinbach; W Culp; B L Brandt
Journal:  Nature       Date:  1974-05-17       Impact factor: 49.962

Review 6.  Properties of human malignant glioma cells in vitro.

Authors:  J Pontén; B Westermark
Journal:  Med Biol       Date:  1978-08

7.  Disappearance of Ca2+-sensitive, phospholipid-dependent protein kinase activity in phorbol ester-treated 3T3 cells.

Authors:  A Rodriguez-Pena; E Rozengurt
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

8.  Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C.

Authors:  H Hidaka; M Inagaki; S Kawamoto; Y Sasaki
Journal:  Biochemistry       Date:  1984-10-09       Impact factor: 3.162

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  The enzymatic iodination of the red cell membrane.

Authors:  A L Hubbard; Z A Cohn
Journal:  J Cell Biol       Date:  1972-11       Impact factor: 10.539

View more
  35 in total

1.  Cytoskeletal reorganization induced by engagement of the NG2 proteoglycan leads to cell spreading and migration.

Authors:  X Fang; M A Burg; D Barritt; K Dahlin-Huppe; A Nishiyama; W B Stallcup
Journal:  Mol Biol Cell       Date:  1999-10       Impact factor: 4.138

2.  NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors.

Authors:  Leonard L Jones; Yu Yamaguchi; William B Stallcup; Mark H Tuszynski
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

3.  Deposition of the NG2 proteoglycan at nodes of Ranvier in the peripheral nervous system.

Authors:  S Martin; A K Levine; Z J Chen; Y Ughrin; J M Levine
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

4.  The multi-PDZ domain protein MUPP1 is a cytoplasmic ligand for the membrane-spanning proteoglycan NG2.

Authors:  D S Barritt; M T Pearn; A H Zisch; S S Lee; R T Javier; E B Pasquale; W B Stallcup
Journal:  J Cell Biochem       Date:  2000-08-02       Impact factor: 4.429

Review 5.  Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?

Authors:  K E Rhodes; J W Fawcett
Journal:  J Anat       Date:  2004-01       Impact factor: 2.610

6.  Immunohistochemical study of NG2 chondroitin sulfate proteoglycan expression in the small and large intestines.

Authors:  Nobuo Terada; Nobuhiko Ohno; Shinichi Murata; Ryohei Katoh; William B Stallcup; Shinichi Ohno
Journal:  Histochem Cell Biol       Date:  2006-04-20       Impact factor: 4.304

7.  Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3.

Authors:  James M Massey; Jeremy Amps; Mariano S Viapiano; Russell T Matthews; Michelle R Wagoner; Christopher M Whitaker; Warren Alilain; Alicia L Yonkof; Abdelnaby Khalyfa; Nigel G F Cooper; Jerry Silver; Stephen M Onifer
Journal:  Exp Neurol       Date:  2007-04-12       Impact factor: 5.330

Review 8.  NG2: a component of the glial scar that inhibits axon growth.

Authors:  Andrew M Tan; Weibing Zhang; Joel M Levine
Journal:  J Anat       Date:  2005-12       Impact factor: 2.610

9.  Matrix metalloproteinase-14 both sheds cell surface neuronal glial antigen 2 (NG2) proteoglycan on macrophages and governs the response to peripheral nerve injury.

Authors:  Tasuku Nishihara; Albert G Remacle; Mila Angert; Igor Shubayev; Sergey A Shiryaev; Huaqing Liu; Jennifer Dolkas; Andrei V Chernov; Alex Y Strongin; Veronica I Shubayev
Journal:  J Biol Chem       Date:  2014-12-08       Impact factor: 5.157

10.  Differing in vitro survival dependency of mouse and rat NG2+ oligodendroglial progenitor cells.

Authors:  Makoto Horiuchi; Tullia Lindsten; David Pleasure; Takayuki Itoh
Journal:  J Neurosci Res       Date:  2010-04       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.